U.S. Software Report Interpretation

Overview

This U.S. Software roundup examines whether higher interest rates change the sector's debt outlook. Barclays concludes that debt is generally benign across its coverage, while AI-infrastructure companies require closer monitoring because rapid, debt-funded capacity expansion raises execution requirements.

Core views

Barclays reviews total debt, leverage, maturities, floating-rate exposure and convertibles across U.S. software coverage as interest rates rise. The firm finds that Oracle, IBM, Microsoft and CoreWeave carry the largest net-debt balances. For Oracle, Microsoft and CoreWeave, debt largely supports AI build-out; IBM's position is largely M&A-driven. The report considers the sector-wide picture manageable for most vendors rather than a broad balance-sheet problem. The principal exception is AI infrastructure. WhiteFiber and CoreWeave are the only covered companies above 3x net debt/adjusted EBITDA, at 14.9x and 6.0x respectively. Barclays argues these ratios are temporarily distorted because the companies incur substantial debt to finance large AI data-center projects before revenue is recognized, owing to project lead times and server installation. Their smaller EBITDA bases and fast capacity additions make this timing effect more pronounced than at Microsoft or Oracle. Barclays expects leverage ratios eventually to normalize, but says debt will keep rising while AI-compute demand substantially exceeds supply; in a higher-rate setting, that raises the bar for execution. The firm takes comfort from recent AI-compute pricing strength and healthy unit economics on signed contracts. Maturity risk appears contained. DigitalOcean's recent equity raise removes its near-term issue for FY26. Oracle and IBM have the largest 2027 maturities, but Barclays cites healthy cash balances and balance-sheet capacity. OpenText has maturities spreading from 2027 through 2031, potentially requiring refinancing, though the report does not view this as problematic given its healthy cash-flow generation. Floating-rate exposure is another pressure point in a potentially higher-rate environment. CoreWeave is the most active user of delayed-draw term loans, secured by the long-term customer contracts and GPU deployments they finance. Salesforce also has meaningful exposure through a $6bn term-loan credit agreement entered in March 2026 to refinance Informatica credit agreements. Barclays notes that Salesforce's modest leverage also reflects M&A and opportunistic share repurchases. Convertible debt is broadly benign on an aggregate basis, although AI-infrastructure providers again feature prominently. CoreWeave, WhiteFiber and DigitalOcean have converts outstanding; DigitalOcean subsequently took action after Q2 to reduce leverage. CoreWeave's proposed $3bn convertible senior notes offering is additional to the tabled exposure and accompanies an ATM equity offering. Barclays flags WhiteFiber's relatively high effective yield on its recent convertible issuance as something to monitor as it expands colocation and AI-cloud capacity. Snowflake's converts, Datadog's issuance and the remaining DigitalOcean 2030 convertibles are in the money following share performance. The roundup also updates several company-specific developments. CoreWeave proposed $3.0bn of convertibles and a 35mn-share ATM, implying about $6.4bn of financing before fees using September 16 pricing; Barclays sees the more equity-based mix as a deal-mix issue rather than a strategic shift. More importantly, the company reported newly signed three-to-six-month compute contracts at about $40mn per MW, which Barclays considers a positive indicator for compute pricing. For Intuit, Barclays says management credibly explained that attention to major strategic bets and higher-end QuickBooks and TurboTax customers weakened new-customer acquisition, affecting future upsell and prompting a major FY27 guidance reset. Product improvements through Intuit Intelligence could make the issue fixable, but the firm believes results—not explanations—will be needed to improve investor sentiment, with tax results not expected until April or May; it nevertheless sees good long-term value. At Salesforce, Barclays sees growing management confidence in the company's AI strategy, though it does not expect the analyst day to be a major near-term share catalyst. Dreamforce introduced AIForce, Koa, broader cloud partnerships and integrations, while customer conversations pointed to choice among AI interfaces rather than wholesale replacement of existing CRM interfaces. The firm also observes strong customer interest at the event as counterevidence to the AI-bear narrative around SaaS and Salesforce. Other updates include Oracle's Q1 growth inflection to 30% year on year from 21%, with Barclays expecting further acceleration, improved financing clarity and operating-expense discipline to offset gross-margin mix effects. Barclays raises Oracle's target price to $252 from $250 and maintains Overweight. Veeva's global Vault CRM win at Amgen brings confirmed adoption to 13 of the top 20 pharmaceutical companies, versus six confirmed Salesforce customers and one undecided; Barclays views the competitive decision as nearing its end, potentially by end-2026. The report also highlights AI-security concerns, arguing that increasingly capable reasoning models and recent rogue-AI examples warrant broader industry debate and a framework for controlling output.

Analysis framework

Barclays first compares balance-sheet debt, cash, net leverage and debt as a share of enterprise value across covered vendors. It then evaluates maturity schedules, floating-rate instruments and convertible bonds to identify refinancing and rate sensitivity, before connecting those findings to AI-infrastructure project economics and selected company developments.

Methodology notes

• Corporate Fundamentals and FinanceOperating and Financial Leverage Analysis

  Net debt and net debt-to-adjusted-EBITDA comparison

  The report compares debt after cash with adjusted EBITDA to assess which companies have the greatest financial leverage and why their ratios differ.

• OtherYield curve analysis

  Debt-maturity and floating-rate exposure review

  The report examines when obligations fall due and which debt reprices with rates to judge refinancing and higher-rate sensitivity.

• Industry AnalysisUpstream-Midstream-Downstream Transmission

  AI data-center CapEx-to-revenue timing

  Barclays explains that debt-funded infrastructure spending precedes revenue from installed capacity, affecting leverage metrics during expansion.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• CoreWeave (CRWV)

  AI-infrastructure provider with elevated leverage and large new financing.

  Strengths

  Recent short-term compute contracts at about $40mn per MW and healthy unit economics on signed contracts.

  Weaknesses

  6.0x net debt/adjusted EBITDA and continued reliance on capacity financing.

  Comparison

  Along with WhiteFiber, it is one of only two vendors above 3x leverage in Barclays' coverage.

  Risks

  Higher rates and the timing gap between data-center CapEx and revenue recognition raise execution requirements.

• WhiteFiber (WYFI)

  AI-infrastructure and colocation provider with the highest reported leverage.

  Strengths

  Barclays expects leverage to normalize as capacity projects mature.

  Weaknesses

  14.9x net debt/adjusted EBITDA and a relatively high effective yield on recent converts.

  Comparison

  Leverage timing effects are more pronounced than at large profitable AI investors such as Microsoft and Oracle.

  Risks

  Debt-funded expansion of colocation and AI-cloud capacity requires monitoring.

• Oracle (ORCL)

  Large software vendor investing in AI infrastructure.

  Strengths

  Q1 growth reached 30% year on year, cash and balance-sheet capacity support 2027 maturities, and financing clarity improved.

  Weaknesses

  Lower gross margin from mix effects.

  Comparison

  Unlike smaller AI-infrastructure vendors, its large profitable base limits leverage-ratio timing distortion.

• Veeva Systems (VEEV)

  Covered software company benefiting from Vault CRM adoption.

  Strengths

  Amgen's global deployment brings Vault CRM to 13 confirmed top-20 pharmaceutical customers.

  Comparison

  Six top-20 pharmaceutical companies are confirmed Salesforce customers, with one customer undecided.

Key data

• CoreWeave net debt / adjusted EBITDA6.0xAbove 3x and tied to AI data-center capacity expansion.
• WhiteFiber net debt / adjusted EBITDA14.9xHighest ratio in the reviewed table; Barclays views AI build-out timing as a distortion.
• CoreWeave proposed financing~$6.4bn before fees~$3.5bn from convert plus option and $2.9bn from the ATM equity offering, based on September 16 pricing.
• CoreWeave short-term compute pricing~$40mn per MWThree-to-six-month contracts; calculated as annualized revenue divided by power required.
• Oracle Q1 growth30% YoYUp from 21%; Barclays expects growth to continue accelerating.
• Veeva Vault CRM top-20 pharma adoption13 confirmed customersVersus six confirmed Salesforce customers and one undecided company.

Impact & implications

Barclays' sector conclusion is that higher rates do not create a broad software debt problem. The implications are most significant for AI-infrastructure providers, where financing, pricing, contract economics and the conversion of capacity investment into revenue will determine whether elevated leverage normalizes as expected.

Risks

• Higher interest rates increase the execution bar for debt-funded AI-infrastructure capacity expansion.
• CoreWeave and WhiteFiber face timing risk as CapEx and debt are incurred before revenue recognition.
• WhiteFiber's relatively high effective yield on recent convertible debt merits monitoring.
• Intuit has no near-term catalyst before tax results are available in April or May.

What to watch

• AI-compute pricing and unit economics on newly signed CoreWeave contracts.
• Whether CoreWeave and WhiteFiber convert installed capacity into revenue and normalize leverage.
• Oracle and IBM's 2027 maturity management and OpenText's refinancing cadence from 2027 to 2031.
• The remaining top-20 pharmaceutical decision between Veeva Vault CRM and Salesforce by end-2026.
• Results from Intuit's next tax season and progress in new-customer acquisition.